Search publications

Publications

  • Catella S, Gendreau RM, Kraus AC, Vega N, Rosenbluth MJ, Soefje S, Malhotra S, Luciano JV, McCracken LM, Williams DA and Arnold LM.

    Self-guided digital acceptance and commitment therapy for fibromyalgia management: results of a randomized, active-controlled, phase II pilot clinical trial

    JOURNAL OF BEHAVIORAL MEDICINE . 47(1): 27-42.

    [doi:10.1007/s10865-023-00429-3]

  • Castaño-Asins JR, Sanabria JP, Luciano JV, Barceló-Soler A, Martín-López LM, Del Arco-Churruca A, Lafuente-Baraza J, Bulbena A, Pérez-Solà V and Montes-Pérez A.

    Effectiveness of Acceptance and Commitment Therapy (ACT) for the Management of Postsurgical Pain: Study Protocol of a Randomized Controlled Trial (SPINE-ACT Study)

    Journal of Clinical Medicine . 12(12): .

    [doi:10.3390/jcm12124066]

  • Sanabria JP, Doval E, Bernadàs A, Angarita-Osorio N, Colomer A, Evans-Lacko S, Thornicroft G, Luciano JV and Rubio-Valera M.

    Over 40 years (1981-2023) assessing stigma with the Community Attitudes to Mental Illness (CAMI) scale: a systematic review of its psychometric properties

    Systematic Reviews . 12(1): 66-66.

    [doi:10.1186/s13643-023-02230-4]

  • Martínez-Rubio D, Colomer A, Sanabria JP, Pérez A, Navarrete J, Martínez-Brotóns C, Escamilla C, Muro A, Montero J, Luciano JV and Feliu A.

    How mindfulness, self-compassion, and experiential avoidance are related to perceived stress in a sample of university students

    PLoS One . 18(2): . Number of citations: 2

    [doi:10.1371/journal.pone.0280791]

  • Wiangkham T, Phungwattanakul N, Rinpol T, Somsiri A, Mainoiy S, Bannathong T, Sanso S, Kongmee I, Jaiyote S, Kuesoongnern S, Sookcharoen P, Laoruengthana A, Suwanmongkhon W, Luciano JV and Neblett R.

    Central Sensitisation Inventory-Thai version: translation, cross-cultural adaptation, and psychometric evaluation in chronic non-specific neck pain.

    DISABILITY AND REHABILITATION . 45(25): 1-8. Number of citations: 1

    [doi:10.1080/09638288.2022.2149863]

  • Serrat M, Ferrés S, Auer W, Almirall M, Lluch E, D'Amico F, Maes M, Lorente S, Navarrete J, Montero J, Neblett R, Nijs J, Borràs X, Luciano JV and Feliu A.

    Effectiveness, cost-utility and physiological underpinnings of the FIBROWALK multicomponent therapy in online and outdoor format in individuals with fibromyalgia: Study protocol of a randomized, controlled trial (On&Out study).

    FRONTIERS IN PHYSIOLOGY . 13: 1046613-1046613. Number of citations: 1

    [doi:10.3389/fphys.2022.1046613]

  • Serrat M, Albajes K, Navarrete J, Almirall M, Lluch Girbés E, Neblett R, Luciano JV, Moix J and Feliu A.

    Effectiveness of two video-based multicomponent treatments for fibromyalgia: The added value of cognitive restructuring and mindfulness in a three-arm randomised controlled trial.

    BEHAVIOUR RESEARCH AND THERAPY . 158: 104188-104188. Number of citations: 7

    [doi:10.1016/j.brat.2022.104188]

  • Sanabria JP, Colomer A, Carmona-Cervelló M, Feliu A, Borràs X, Grasa M, Esteve M, Maes M, Edo S, Sanz A and Luciano JV.

    Immune-inflammatory and hypothalamic-pituitary-adrenal axis biomarkers are altered in patients with non-specific low back pain: A systematic review.

    FRONTIERS IN IMMUNOLOGY . 13: 945513-945513. Number of citations: 3

    [doi:10.3389/fimmu.2022.945513]

  • Lopez-del-Hoyo, Yolanda, Collado-Navarro, Carlos, Pérez A, Garcia-Campayo, Javier, Lopez-Montoyo, Alba, Feliu A, Luciano JV and Montero J.

    Assessing mindfulness and self-compassion facets as mediators of change in patients with depressive, anxious and adjustment disorders: Secondary data analysis of a randomized controlled trial

    Journal of Contextual Behavioral Science . 24: 171-178. Number of citations: 2

    [doi:10.1016/j.jcbs.2022.05.007]

  • Colomer A, Sanabria JP, Hernández-Negrín H, Borràs X, Suso-Ribera C, García-Palacios A, Muchart-Lopez J, Munuera-del Cerro JL, Francesco D'Amico, Maes M, Younger JW, Feliu A, Rozadilla A and Luciano JV.

    Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost-utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study)

    BMJ Open . 12(1): . Number of citations: 5

    [doi:10.1136/bmjopen-2021-055351]